SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-000404
Filing Date
2022-01-06
Accepted
2022-01-06 07:13:00
Documents
14
Period of Report
2022-01-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tsvt-20220106.htm   iXBRL 8-K 36824
2 EX-99.1 exhibit991-8xk162022.htm EX-99.1 22986
6 header1a.jpg GRAPHIC 32499
  Complete submission text file 0001628280-22-000404.txt   252883

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tsvt-20220106.xsd EX-101.SCH 2008
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tsvt-20220106_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tsvt-20220106_pre.xml EX-101.PRE 13142
8 EXTRACTED XBRL INSTANCE DOCUMENT tsvt-20220106_htm.xml XML 11585
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 22513620
SIC: 2834 Pharmaceutical Preparations